News - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

226 to 250 of 6979 results

Teva files citizen petition with FDA regarding Copaxone complexity

Teva files citizen petition with FDA regarding Copaxone complexity

03-07-2014

Teva Pharmaceutical Industries says it has filed a citizen petition regarding the approvability of purported…

CopaxoneLegalNeurologicalPatentsPharmaceuticalRegulationTeva Pharmaceutical IndustriesUSA

Opportunities ripe for Pharma in Ghana and Nigeria

03-07-2014

Strong business opportunities exist for big pharmaceutical and generic pharmaceutical companies in Ghana…

HealthcareMarkets & MarketingPharmaceutical

Isis Pharma earns $1 million GSK milestone on hepatitis B virus program

Isis Pharma earns $1 million GSK milestone on hepatitis B virus program

03-07-2014

USA-based Isis Pharmaceuticals has earned yet another $1 million payment from UK pharma giant GlaxoSmithKline,…

Anti-viralsFinancialGlaxoSmithKlineIsis PharmaceuticalsPharmaceuticalResearch

JAMA study shows bone marrow transplants can reverse sickle cell disease

03-07-2014

Bone marrow transplants can reverse severe sickle cell disease in adults, according to new data published…

HematologyPharmaceuticalResearchUSA

New OECD data shows Australia lagging in investing in medicines

New OECD data shows Australia lagging in investing in medicines

03-07-2014

Data newly released by the Organization for Economic Cooperation and Development (OECD) reveals that…

AustraliaFinancialHealthcarePharmaceutical

Eisai’s breast cancer drug Halaven receives MAA in Europe

Eisai’s breast cancer drug Halaven receives MAA in Europe

03-07-2014

The European Commission has issued Marketing Authorization Approval (MAA) for Halaven (eribulin) from…

EisaiEuropeHalavenOncologyPharmaceuticalRegulation

FDA orphan status for Insys’ cannabidiol as treatment for Dravet syndrome

FDA orphan status for Insys’ cannabidiol as treatment for Dravet syndrome

03-07-2014

US specialty pharma firm Insys Therapeutics yesterday revealed that the US Food and Drug Administration…

cannabidiolInsys TherapeuticsNeurologicalPharmaceuticalRare diseasesRegulationUSA

Jazz Pharma gains Americas rights to defibrotide from Sigma-Tau

Jazz Pharma gains Americas rights to defibrotide from Sigma-Tau

02-07-2014

Ireland-headquartered drugmaker Jazz Pharmaceuticals has signed a definitive agreement Pharmaceuticals…

defibrotideGentiumJazz PharmaceuticalsLicensingNephrology and HepatologyNorth AmericaPharmaceuticalSigma-TauSouth America

FDA accepts Boehringer’s nintedanib NDA; granted priority review for IPF

FDA accepts Boehringer’s nintedanib NDA; granted priority review for IPF

02-07-2014

The US subsidiary of German family-owned drug major Boehringer Ingelheim says that the New Drug Application…

Boehringer IngelheimnintedanibPharmaceuticalRegulationRespiratory and PulmonaryUSA

Salix leaps on positive Ph III results with Xifaxan in IBS-D

Salix leaps on positive Ph III results with Xifaxan in IBS-D

02-07-2014

US drugmaker Salix Pharmaceuticals’ saw its shares leap as much as 13% after the company released new…

Gastro-intestinalsPharmaceuticalResearchrifaximinSalix PharmaceuticalsXifaxan

Novartis takes action as former employee is arrested in Japan

Novartis takes action as former employee is arrested in Japan

02-07-2014

Swiss drug major Novartis (NOVN: VX) said yesterday that Novartis Pharma K.K. (NPKK) understands that…

JapanLegalNovartisPharmaceutical

Boehringer submits tiotropium + olodaterol Respimat for European approval in COPD

Boehringer submits tiotropium + olodaterol Respimat for European approval in COPD

02-07-2014

German family-owned pharma major Boehringer Ingelheim says it has submitted Marketing Authorization Applications…

Boehringer IngelheimEuropePharmaceuticalRegulationRespiratory and Pulmonarytiotropium + olodaterol Respimat

Pozen re-files for US approval of PA8140/PA32540

Pozen re-files for US approval of PA8140/PA32540

02-07-2014

US drug firm Pozen has resubmitted the New Drug Application for PA8140/PA32540 (aspirin and omeprazole)…

AspirinCardio-vascularOmeprazolePA8140/PA32540PharmaceuticalPozenRegulationUSA

US FDA outlines expectations for human drug compounders

US FDA outlines expectations for human drug compounders

02-07-2014

Yesterday, the US Food and Drug Administration issued several policy documents regarding compounded drug…

PharmaceuticalRegulationUSA

UK launches fresh fight against antimicrobial resistance

UK launches fresh fight against antimicrobial resistance

02-07-2014

The UK prime minister David Cameron has said he wants Britain to lead the way in the battle against antimicrobial…

Antibiotics and Infectious diseasesHealthcarePharmaceuticalUK

Thrombogenics’ Jetrea gains first Latin American approval in Uruguay

Thrombogenics’ Jetrea gains first Latin American approval in Uruguay

02-07-2014

Belgium-based biopharma firm ThromboGenics has said that Jetrea (ocriplasmin) has been approved in Uruguay…

JetreaOphthalmicsPharmaceuticalRegulationThromboGenicsUruguay

New entrants in chronic lymphocytic leukemia will raise market value to $3.3 billion by 2018

New entrants in chronic lymphocytic leukemia will raise market value to $3.3 billion by 2018

02-07-2014

The introduction of several new drugs will accelerate growth in the chronic lymphocytic leukemia treatment…

EuropeidelalisibImbruvicaMarkets & MarketingOncologyPharmaceuticalUSA

Medicines Australia submits new transparency reforms to ACCC

Medicines Australia submits new transparency reforms to ACCC

02-07-2014

Trade body Medicines Australia has applied for authorization of the 18th Edition of its Code of Conduct…

AustraliaPharmaceuticalRegulation

CureVac in deal with Sanofi Pasteur for mRNA-based prophylactic vaccine

01-07-2014

German clinical-stage biopharma company CureVac has entered into an exclusive license agreement with…

LicensingPharmaceuticalSanofiSanofi PasteurVaccines

Boston Strategics in-licenses Eisai’s cancer candidate E6201

01-07-2014

US clinical-stage drug R&D company Boston Strategics Corp has entered into an exclusive licensing and…

Boston Strategics CorpE6201EisaiLicensingOncologyPharmaceutical

ALK appoints new Executive Vice President for Product Supply

ALK appoints new Executive Vice President for Product Supply

01-07-2014

Danish allergy specialist ALK-Abello has appointed Helle Skov as new Executive Vice President (Product…

ALK AbelloAlk-AbelloBoardroomDenmarkPharmaceutical

Transcept and Paratek join forces in reverse takeover

Transcept and Paratek join forces in reverse takeover

01-07-2014

US pharma company Transcept Pharmaceuticals and privately-held biopharmaceutical company Paratek Pharmaceuticals…

Antibiotics and Infectious diseasesMergers & AcquisitionsParatek PharmaceuticalsPharmaceuticalTranscept PharmaUSA

226 to 250 of 6979 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top